sarms
MK2866 (Ostarine) - Vascular
33mg / ml
Order within 00:02:04 for same-day dispatch
To get a discount, simply add products to the cart and continue to the checkout page, and the discount will automatically be applied.
About this product
VASCULAR (MK2866): Selective Androgen Receptor Modulator for Muscle and Bone Research
VASCULAR contains MK2866, also known as Ostarine, a well studied Selective Androgen Receptor Modulator (SARM) developed to investigate androgen receptor signalling in muscle and bone tissue. Unlike traditional anabolic agents, MK2866 selectively targets androgen receptors in specific tissues while minimising activity in others, making it a frequent subject of research into lean muscle preservation, physical function, and bone health. Originally developed for conditions involving muscle wasting and reduced physical performance, MK2866 has been examined in both clinical and preclinical studies for its effects on lean body mass, strength-related markers, recovery capacity, and musculoskeletal support. Its selective mechanism has positioned it as a reference compound in SARM research.
Product Summary Table
| Compound Name | MK2866 (Ostarine) |
| Compound Class | Selective Androgen Receptor Modulator (SARM) |
| Primary Target | Androgen receptor (selective) |
| Mechanism of Action | Tissue selective androgen receptor activation |
| Form | Oral research solution (33 mg/ml) |
| Country of Origin | Australia |
| Storage | Store in a cool, dark place according to laboratory handling guidelines |
| Standard | Research Grade |
In Vivo Research Benefits
MK2866 has been evaluated in multiple research models focused on muscle function, bone density, and physical performance.
- Lean muscle mass preservation observed in clinical studies involving muscle wasting conditions.
- Improved physical function and strength-related performance markers in controlled trials.
- Bone density support associated with selective androgen receptor activation.
- Enhanced recovery capacity linked to improved muscle tissue signalling.
- Minimal off-target androgenic activity compared to non-selective anabolic agents.
Benefits of VASCULAR (MK2866)
- Selective Androgen Signalling targeting muscle and bone tissue.
- Lean Mass Support during caloric deficit or reduced training load research models.
- Functional Performance Research involving strength and endurance markers.
- Bone Health Investigation relevant to injury prevention and skeletal support studies.
- Well Characterised SARM with human clinical trial data available.
Studies and Additional Info
- Clinical trials examining MK2866 in muscle wasting and sarcopenia models
- Research on selective androgen receptor activation and bone density
- Studies assessing physical function and recovery markers
- Comparative research between MK2866 and traditional androgenic compounds
Disclaimer: VASCULAR (MK2866) is supplied strictly for laboratory research purposes. It is not intended for human consumption or human use.
Frequently Asked Questions
What is MK2866 studied for?
MK2866 is studied for its effects on lean muscle mass, physical function, bone density, and selective androgen receptor signalling.
Is MK2866 an anabolic steroid?
No. MK2866 is a Selective Androgen Receptor Modulator and does not share the same broad androgenic profile as anabolic steroids.
Does MK2866 affect bone health?
Yes. Research indicates selective androgen receptor activation may support bone density and skeletal strength.
Is MK2866 orally active in research?
Yes. MK2866 is orally bioavailable, which has been documented in clinical and preclinical studies.
Is MK2866 approved for human use?
No. MK2866 remains a research compound and is not approved for human consumption.
